Cerebral Blood Flow in Orthostatic Intolerance
- PMID: 39895557
- PMCID: PMC12074713
- DOI: 10.1161/JAHA.124.036752
Cerebral Blood Flow in Orthostatic Intolerance
Abstract
Cerebral blood flow (CBF) is vital for delivering oxygen and nutrients to the brain. Many forms of orthostatic intolerance (OI) involve impaired regulation of CBF in the upright posture, which results in disabling symptoms that decrease quality of life. Because CBF is not easy to measure, rises in heart rate or drops in blood pressure are used as proxies for abnormal CBF. These result in diagnoses such as postural orthostatic tachycardia syndrome and orthostatic hypotension. However, in many other OI syndromes such as myalgic encephalomyelitis/chronic fatigue syndrome and long COVID, heart rate and blood pressure are frequently normal despite significant drops in CBF. This often leads to the incorrect conclusion that there is nothing hemodynamically abnormal in these patients and thus no explanation or treatment is needed. There is a need to measure CBF, as orthostatic hypoperfusion is the shared pathophysiology for all forms of OI. In this review, we examine the literature studying CBF dysfunction in various syndromes with OI and evaluate methods of measuring CBF including transcranial Doppler ultrasound, extracranial cerebral blood flow ultrasound, near infrared spectroscopy, and wearable devices.
Keywords: ME/CFS; POTS; cerebral blood flow; long COVID; orthostatic intolerance.
Conflict of interest statement
Dr Miller is a consultant to Lumia Health. Dr Fudim was supported by the National Institutes of Health, Reprieve, Sardocor, and Doris Duke. He is a consultant/has ownership interest in Abbott, Ajax, Alio Health, Alleviant, Artha, Audicor, AxonTherapies, Bayer, Bodyguide, Bodyport, Boston Scientific, Broadview, Cadence, Cardioflow, CVRx, Daxor, Edwards LifeSciences, Echosens, EKO, Feldschuh Foundation, Fire1, FutureCardia, Galvani, Gradient, Hatteras, HemodynamiQ, Impulse Dynamics, Intershunt, Medtronic, Merck, NovoNordisk, NucleusRx, NXT Biomedical, Orchestra, Pharmacosmos, Presidio, Procyreon, Proton Intelligence, ReCor, SCPharma, Shifamed, Splendo, Lumia Health, Summacor, SyMap, Verily, Vironix, Viscardia, and Zoll. Dr Tandri is a consultant to Lumia Health and Abbott. Dr Frazier Mills is a consultant to Medtronic, Johnson & Johnson, and Boston Scientific. Dr Raj is a consultant to Theravance Biopharma, Amneal Pharma, Servier Affaires Medicales, Regeneron, argenx BV, Antag Pharma, and Lumia Health. Jeroen Molinger has received honoraria or travel expenses for lectures from Abbott, Baxter, Danone‐Nutricia, Nestlé, Corsano Health, CalibreBio, VO2Master, Rockley Photonics, Vital Impact, Train‐Red, Vyaire Medical, MuscleSound. Dr Goyal received consulting fees from Agepha Pharma, Akros Pharma, Axon Therapies, Bayer HealthCare Pharmaceuticals, and Sensorum Health.
Figures




References
-
- Sheldon RS, Grubb BP 2nd, Olshansky B, Shen WK, Calkins H, Brignole M, Raj SR, Krahn AD, Morillo CA, Stewart JM, et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12:e41–e63. doi: 10.1016/j.hrthm.2015.03.029 - DOI - PMC - PubMed
-
- Stiles LE. Chronic fatigue syndrome and the autonomic nervous system. Chronic Fatigue Syndrome and the Autonomic Nervous System. Primer on the Autonomic Nervous System: In; 2023. doi: 10.1016/B978-0-323-85492-4.00027-2 - DOI
-
- Shaw BH, Stiles LE, Bourne K, Green EA, Shibao CA, Okamoto LE, Garland EM, Gamboa A, Diedrich A, Raj V, et al. The face of postural tachycardia syndrome ‐ insights from a large cross‐sectional online community‐based survey. J Intern Med. 2019;286:438–448. doi: 10.1111/joim.12895 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources